ZA Biomedical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A1

  • Investors
  • 3

ZA Biomedical General Information

Description

Manufacturer of innovative biopharmaceutical products intended for HPV-related diseases and various cancers. The company specailises in cancer therapeutic vaccines, topical peptide ointments for multidrug-resistant bacteria, treatments for genital warts and melanoma, and peptide-drug conjugates for advanced tumours, thereby improving patient outcomes in oncology and infectious disease care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room A, 5th Floor, East, Building A3
  • Number 6 Shennong Road, Torch Development Zone
  • Zhongshan, Guangdong 528400
  • China
+86 0760
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Room A, 5th Floor, East, Building A3
  • Number 6 Shennong Road, Torch Development Zone
  • Zhongshan, Guangdong 528400
  • China
+86 0760

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ZA Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A1) 22-Sep-2025 Completed Generating Revenue
3. Early Stage VC (Series A) 15-Sep-2022 Completed Generating Revenue
2. Early Stage VC 01-Dec-2020 $756K $1.81M Completed Generating Revenue
1. Seed Round 01-Nov-2019 $1.06M $1.06M Completed Startup
To view ZA Biomedical’s complete valuation and funding history, request access »

ZA Biomedical Patents

ZA Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12702702-B2 Application of caerin 1.1/1.9 combined with anti-cd47 antibody in preparing drug for treating melanoma Active 22-Nov-2022
US-20250288656-A1 Application of caerin 1.1/1.9 combined with anti-cd47 antibody in preparing drug for treating melanoma Active 22-Nov-2022
WO-2024109339-A1 Use of caerin1.1/1.9 combined with anti-cd47 antibody in preparation of drug for treatment of melanoma Inactive 22-Nov-2022
AU-2017385913-A1 Pharmaceutical composition comprising f1 and f3 polypeptides, and application thereof in treating hpv infection Active 27-Dec-2016
AU-2017385913-B2 Pharmaceutical composition comprising f1 and f3 polypeptides, and application thereof in treating hpv infection Active 27-Dec-2016 A61K38/1703
To view ZA Biomedical’s complete patent history, request access »

ZA Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ZA Biomedical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
San Nuo Technology Corporation Minority
Zhongshan Torch Electronic Industry Fund Management Venture Capital Minority
Zhuhai Sanying Equity Investment Fund Management Growth/Expansion Minority
To view ZA Biomedical’s complete investors history, request access »

ZA Biomedical FAQs

  • When was ZA Biomedical founded?

    ZA Biomedical was founded in 2018.

  • Where is ZA Biomedical headquartered?

    ZA Biomedical is headquartered in Zhongshan, China.

  • What is the size of ZA Biomedical?

    ZA Biomedical has 5 total employees.

  • What industry is ZA Biomedical in?

    ZA Biomedical’s primary industry is Drug Discovery.

  • Is ZA Biomedical a private or public company?

    ZA Biomedical is a Private company.

  • What is ZA Biomedical’s current revenue?

    The current revenue for ZA Biomedical is .

  • How much funding has ZA Biomedical raised over time?

    ZA Biomedical has raised $1.81M.

  • Who are ZA Biomedical’s investors?

    San Nuo Technology, Zhongshan Torch Electronic Industry Fund Management, and Zhuhai Sanying Equity Investment Fund Management have invested in ZA Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process